260
Participants
Start Date
January 30, 2022
Primary Completion Date
February 28, 2027
Study Completion Date
May 31, 2027
Cytosorb® 300 ml
patients will receive CytoSorb therapy in addition to standard of care therapy according to applicable guidelines
Department of Nephrology and Medical Intensive Care, Charité - University Medical Center, Berlin
Department of Anesthesiology and Operative Intensive Care Medicine (CBF), Charité - Universitätsmedizin Berlin, Berlin
Center for Emergency and Intensive Care Medicine, Hospital Ernst von Bergmann, Potsdam
Department of Internal Medicine B, Cardiology, Pneumology, Infectious Diseases, Intensive Care Medicine, University Hospital Greifswald, Greifswald
Department of Anesthesiology and Intensive Care Medicine, Rostock University Medical Centre, Rostock
Department of Intensive Care Medicine, University Medical-Center Hamburg-Eppendorf, Hamburg
Klinikum Emden, Emden
Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr- University Bochum, Klinikum Herford, Herford, Germany, Herford
Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen
Department of Nephrology, University Hospital Essen, Essen
Department of Anesthesiology, Operative Intensive Care Medicine, Pain Management and Emergency Medicine, Hospital Ibbenbüren, Ibbenbueren
Department of Anesthesiology, Intensive-Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main
Department of Internal Medicine II, Technical University of Munich, Munich
Clinic for Interdisciplinary Intensive Care and Intermediate Care, HELIOS Hospital Erfurt, Erfurt
Department of Anesthesiology and Critical Care Medicine, University Hospital of Dresden, Dresden
Department of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg
Department of Anaesthesiology and Intensive Care Medicine, Technical University of Munich, Munich
Department of Internal Medicine, Neurology and Dermatology, Interdisciplinary Internal Intensive Care Medicine, University Leipzig, Leipzig
Collaborators (1)
BRAHMS GmbH
UNKNOWN
MedInnovation GmbH
INDUSTRY
CytoSorbents Europe GmbH
INDUSTRY